Pisit Duke Pitukcheewanont's most recent trade in Lumos Pharma Inc was a trade of 274 Common Stock done at an average price of $2.3 . Disclosure was reported to the exchange on July 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lumos Pharma Inc | Pisit Duke Pitukcheewanont | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.26 per share. | 01 Jul 2024 | 274 | 16,836 (0%) | 0% | 2.3 | 620 | Common Stock |
Lumos Pharma Inc | Pisit Duke Pitukcheewanont | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.25 per share. | 01 Jun 2024 | 320 | 16,610 (0%) | 0% | 2.3 | 720 | Common Stock |
Lumos Pharma Inc | Pisit Duke Pitukcheewanont | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 41,500 | 41,500 | - | - | Stock Option (Right to Buy) | |
Lumos Pharma Inc | Pisit Duke Pitukcheewanont | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 2.84 per share. | 01 Apr 2024 | 6,000 | 16,930 (0%) | 0% | 2.8 | 17,040 | Common Stock |